Antagonist of MCP-1 function, and compositions and methods of use thereof
US6962926B2 · kind B2 · utility
9Cited by
11References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Aug 8, 2003 |
| Grant date | Nov 8, 2005 |
| Priority date | — |
| Expiry date | Aug 8, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K9/4866
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of formula A and formula B: and their pharmaceutically acceptable salts, compositions comprising them, methods for their use, and their use in the preparation of medicaments. The compounds are antagonists of MCP-1 function, and are useful in the prevention and treatment of chronic or acute inflammatory or autoimmune diseases, such as multiple sclerosis, and in the prevention and treatment of allergic hypersensitivity disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.